Development
IperionX Limited
IPX
$38.29
-$0.33-0.85%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.18M | 3.18M | 2.74M | 2.74M | 3.29M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.06M | 5.06M | 4.49M | 4.49M | 4.34M |
| Operating Income | -5.06M | -5.06M | -4.49M | -4.49M | -4.34M |
| Income Before Tax | -5.25M | -5.25M | -4.35M | -4.35M | -4.38M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.25M | -5.25M | -4.35M | -4.35M | -4.38M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.25M | -5.25M | -4.35M | -4.35M | -4.38M |
| EBIT | -5.06M | -5.06M | -4.49M | -4.49M | -4.34M |
| EBITDA | -5.02M | -5.02M | -4.45M | -4.48M | -4.33M |
| EPS Basic | -0.03 | -0.03 | -0.02 | -0.02 | -0.03 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.01 | -0.01 | -0.02 |
| EPS Diluted | -0.03 | -0.03 | -0.02 | -0.02 | -0.03 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.01 | -0.01 | -0.02 |
| Average Basic Shares Outstanding | 209.90M | 209.90M | 190.16M | 190.16M | 145.90M |
| Average Diluted Shares Outstanding | 209.90M | 209.90M | 190.16M | 190.16M | 145.90M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |